These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33368394)

  • 1. Novel reversed-phase HPLC method for simultaneous determination of ethynodiol diacetate (EDA)/ethinyl estradiol (EE) in pharmaceutical dosage form.
    Chinta SR; Ponnam V; Katari NK; Ediga SG; Marisetti VM
    Biomed Chromatogr; 2021 May; 35(5):e5055. PubMed ID: 33368394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of ethynodiol diacetate and ethinyl estradiol/mestranol in oral contraceptive tablets by high-performance liquid chromatography.
    Carignan G; Lodge BA; Skakum W
    J Pharm Sci; 1982 Feb; 71(2):264-6. PubMed ID: 7062257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate.
    Vose CW; Butler JK; Williams BM; Stafford JE; Shelton JR; Rose DA; Palmer RF; Breckenridge AM; Orme ML; Serlin MJ
    Contraception; 1979 Feb; 19(2):119-27. PubMed ID: 428229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral contraceptives on lipoprotein lipids: a prospective study.
    Powell MG; Hedlin AM; Cerskus I; Kakis G; Prudham D; Rosenrot P
    Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms, with an emphasis on contraceptive efficacy. A phase IV trial.
    Friedman AJ; Wheeler J
    J Reprod Med; 1991 Apr; 36(4 Suppl):328-33. PubMed ID: 2046081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of ethinylestradiol and norethisterone in an oral contraceptive capsule by reversed-phase high performance liquid chromatography.
    Gluck JA; Shek E
    J Chromatogr Sci; 1980 Nov; 18(11):631-6. PubMed ID: 7451634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of impurity profiles of drugs and related materials: part XXI. HPLC/UV/MS study of the impurity profile of ethynodiol diacetate.
    Babják M; Balogh G; Gazdag M; Görög S
    J Pharm Biomed Anal; 2002 Aug; 29(6):1153-7. PubMed ID: 12110402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and placenta levels of ethynylestradiol in presence of ethynodiol diacetate after oral administration.
    Morvay J; Altorjay I; Sas M
    Horm Res; 1982; 16(4):237-43. PubMed ID: 6890038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of ovarian cyst formation in women taking ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms.
    Friedman AJ; Wheeler JM
    J Reprod Med; 1991 Apr; 36(4 Suppl):345-9. PubMed ID: 2046084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A changing pattern in the association of oral contraceptives and the different groups of congenital limb deficiencies.
    Czeizel AE; Kodaj I
    Contraception; 1995 Jan; 51(1):19-24. PubMed ID: 7750279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives, lipoproteins, and atherosclerosis.
    Adams MR; Clarkson TB; Shively CA; Parks JS; Kaplan JR
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1388-93. PubMed ID: 2220963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
    Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
    Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and application of RP-HPLC method for the quantification of metoclopramide hydrochloride in oral formulations prepared for IVIVC studies.
    Khan A; Naqvi SB; Shoaib MH; Yousaf RI; Khan J; Hanif M; Madni A
    Pak J Pharm Sci; 2012 Jan; 25(1):135-40. PubMed ID: 22186321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability-indicating RP-HPLC method for the quantitative analysis of perindopril erbumine in tablet dosage form.
    Dugga HH; Peraman R; Nayakanti D
    J Chromatogr Sci; 2014 Apr; 52(4):315-20. PubMed ID: 23690066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of gatifloxacin and ambroxol hydrochloride from tablet dosage form using reversed-phase high performance liquid chromatography.
    Shahed M; Nanda R; Dehghan MH; Nasreen H; Feroz S
    Se Pu; 2008 May; 26(3):358-61. PubMed ID: 18724676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a generic RP-HPLC PDA method for the simultaneous separation and quantification of active ingredients in cold and cough medicines.
    Dongala T; Katari NK; Palakurthi AK; Jonnalagadda SB
    Biomed Chromatogr; 2019 Nov; 33(11):e4641. PubMed ID: 31265736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast RP-HPLC Method for the Determination of Bisoprolol.
    Panainte AD; Vieriu M; Ţântaru G; Apostu M; Bibire N
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):720-6. PubMed ID: 30152661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of gliquidone, pioglitazone hydrochloride, and verapamil in formulation and human serum by RP-HPLC.
    Arayne MS; Sultana N; Mirza AZ
    J Chromatogr Sci; 2011 Feb; 49(2):114-7. PubMed ID: 21223635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.